[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: University of Maryland's Open Access Deliberations
- To: liblicense-l@lists.yale.edu
- Subject: Re: University of Maryland's Open Access Deliberations
- From: Jean-Claude Guedon <jean.claude.guedon@umontreal.ca>
- Date: Thu, 7 May 2009 16:49:44 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
IMHO you are completely wrong. Why is OA a problem with the latest research in medicine, and particularly the "latest" research? And, if true, it is a problem for whom? Some publishers perhaps, but what about researchers and students everywhere? Why is talking about OA in fields other than medicine nonsense? I simply do not understand the thrust of this posting. Jean-Claude Guedon Le lundi 04 mai 2009 a 22:22 -0400, Ari Belenkiy a ecrit : >> There is enough evidence that OA increases sales: >> http://delicious.com/Klausgraf/monograph_open_access >> >> Klaus Graf >> >> 2009/5/1 Sandy Thatcher <sgt3@psu.edu>: >> >>> How does one even begin to measure the "economic value" of OA >>> for, say, a work of literary criticism or a monograph on >>> Hume's philosophy? We scholarly publishers would dearly like >>> to believe that spreading our specialized content freely >>> worldwide would be a benefit to civilization, but this is an >>> article of faith for us, not something we have any easy way of >>> quantifying economically. > > Right, it is clear that OA is a problem with the latest research > in Medicine and must be restricted to it. > > Talking about necessity of OA in other fields is just nonsense. > Am I right? > > Ari Belenkiy > Bar-Ilan University > Jean-Claude Guedon Universite de Montreal
- Prev by Date: Elsevier admits error
- Next by Date: Re: University of Maryland's Open Access Deliberations
- Previous by thread: Re: University of Maryland's Open Access Deliberations
- Next by thread: Re: University of Maryland's Open Access Deliberations
- Index(es):